The Nephrology And Urology Incontinence Devices Market is expected to record a CAGR of 4.1% during the forecast period, up from USD 38 Billion in 2021 to reach a valuation of USD 46.4 Billion by 2026.
| Report Attributes | Details |
|---|---|
| Estimated Base Year Value (2021) | USD 38 Billion |
| Anticipated Forecast Value (2026) | USD 46.4 Billion |
| Projected Growth Rate (2022 to 2032) | 4.1% CAGR |
Sales of nephrology and urology incontinence devices are expected to rise due to government measures to support R&D in the field.
For instance, during the virtual KidneyX Summit in July 2020, the United States Department of Health and Human Services (HHS) and the American Society of Nephrology (ASN) revealed the six winners of the USD 3 million KidneyX: Redesign Dialysis Phase 2 competition.
In addition to this, demand for nephrology and urology incontinence devices has also increased due to the focused concentration on providing digital solutions during the Covid-19 pandemic.
The global nephrology and urology devices market is predicted to increase due to the increasing geriatric population.
The sales of nephrology and urology incontinence devices are projected to be hampered by high installation costs for equipment such as lithotripters and sophisticated machines and further projected to contribute to the growth of nephrology and urology incontinence devices market share.
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
Presently, the sales of nephrology and urology incontinent devices are primarily driven by the rising prevalence of chronic kidney disease (CKD), Benign Prostatic Hyperplasia (BPH) and End Stage Renal Disease (ESRD).
Growing awareness programs about these particular diseases and personal hygiene among patients will result in the increased demand for nephrology and urology incontinent devices in the forecast years.
Also, with the increase in healthcare expenditure and favorable reimbursement in the developed countries, the sales of nephrology and urology incontinent devices are expected to have a healthy growth.
Rising incidence rates and health consequences of urological disorders result in the growing demand for nephrology and urology incontinence devices treatments to manage them, boosting the sales of neurology and urology incontinence devices.
Depending on geographic regions, the nephrology and urology incontinence devices market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa.
North America and Europe are expected to capture the most significant sales of nephrology and urology incontinence devices, followed by Asia Pacific countries where the demand for nephrology and urology incontinence devices market is expected to grow due to increased awareness of personal hygiene and an increase in disposable income of middle-class consumers.
Some of the key participating players in the Nephrology And Urology Incontinence Devices Market are Baxter International Inc., C. R. Bard, Inc, Coloplast UK Ltd., Unicharm Corporation., Kimberly-Clark Corporation, Hollister Inc., ConvaTec, B.Braun Melsungen AG, SCA (Svenska Cellulosa Aktiebolaget) and others.
Increased demand for nephrology and urology incontinence devices is predicted to rise due to a growing desire for minimally invasive and non-invasive treatment approaches.
Recent Developments
| Report Attributes | Details |
|---|---|
| Growth Rate | CAGR of 4.1% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2015 to 2020 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in USD Million, Volume in Kilotons and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Regions Covered | North America; Latin America; Europe; APAC; Middle East and Africa |
| Key Countries Profiled | USA, Canada, Mexico, Brazil, Germany, Italy, France, UK, Spain, China, India, Japan, Australia, South Korea, ASEAN, GCC, Israel, South Africa, Central Africa |
| Key Companies Profiled | Baxter International Inc.; C. R. Bard, Inc.; Coloplast UK Ltd.; Unicharm Corporation; Kimerly-Clark Corporation; Hollister Inc.; ConvaTec; B.Braun Melsungen AG; SCA (Svenska Cellulosa Aktiebolaget) |
| Customization Scope | Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. |
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
The nephrology and urology incontinence devices market are predicted to register a CAGR of 4.1% during the forecast period.
Key players holding substantial nephrology and urology incontinence devices market share includes Baxter International Inc., C. R. Bard, Inc, Coloplast UK Ltd., Unicharm Corporation., Kimerly-Clark Corporation, Hollister Inc., ConvaTec, B.Braun Melsungen AG, SCA (Svenska Cellulosa Aktiebolaget) and others.
As per the analysis, the nephrology and urology incontinence devices market share are likely to be USD 46.4 Billion by 2026.
Demand for nephrology and urology incontinence devices market is likely to rise on the back of increasing due to the focused concentration on providing digital solutions during Covid-19 pandemic and the increasing geriatric population.
| Market Estimated Size (2022) | USD 391.6 Million |
|---|---|
| Market Size Projected (2028) | USD 486.4 Million |
| Market Value-based CAGR (2022 to 2028) | ~3.7% |
Explore Therapeutic Device Insights
View Reports
Nephrology and Urology Incontinence Devices Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
